Psoriasis

One size does not fit all

Deucravacitinib FDA approved for plaque psoriasis

Pustular psoriasis flares lead to ED admissions

Hope for new plaque psoriasis treatment

Fortnightly secukinumab better for heavier psoriasis patients

Risankizumab can be used in patients with Crohn’s

Impact of dermatological disease is more than skin deep

Rituximab and non-white ethnicity linked with worse covid outcomes
